Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Marketing
Fierce Pharma
Genentech amplifies breast cancer conversations in new campaign
"About Damn Time" focuses on the journey following initial treatment for HR-positive, HER2-negative early breast cancer.
Zoey Becker
Oct 1, 2026 2:52pm
Fierce Pharma
Novo struggles to appease restless investors with new strategy
Sep 21, 2026 10:50am
Fierce Pharma
Novo CEO talks embracing change and staying bullish amid rebrand
Sep 17, 2026 8:45am
Fierce Pharma
No more Nordisk as Novo goes it alone amid rebranding push
Sep 14, 2026 6:54am
Fierce Pharma
FDA's surprise approval of AZ's oral SERD sets new paradigm
Sep 8, 2026 10:35am
Fierce Pharma
Inside Astellas CEO's plan to counter Xtandi's patent cliff
Jun 11, 2026 6:00pm
